Study leader professor Johann de Bono said: “At the moment assess in the clinic how men with advanced prostate cancer are responding to their treatment. Measuring the levels of circulating tumour cells in blood samples could be a relatively quick and effective way to test men in the ...
The article reports that measuring the serum concentration of prostate-specific antigen (PSA), combined with a rectal examination is a better screening test than rectal examination alone fo...
They also were also more likely to have a poor response to treatment, as measured by a complete prostate-specific antigen (PSA) response. Men with five or more CTCs lived a median 27.9 months after their blood test, compared to 56.2 months for men with one to four CTCs and at least 78...
Your doctor should get the results of your blood test(s) and discuss them with you. Blood tests show whether the levels of different substances in your blood fall within a normal range. Your doctor should discuss any unusual or abnormal results with you....
PSA blood test- a blood test that measures levels of a protein called prostate specific antigen that is manufactured exclusively by the prostate gland; men with prostate problems usually have elevated levels of PSA Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University...
always be accompanied by expression of PSA. Levels can be elevated in the presence of a urinary tract infection or an inflamed prostate. A PSA level over 2.5 ng/mL, or a PSA doubling time (the time required for PSA value to double) of less than 12 years, may be a cause for concern...
Although the PSA blood test is commonly used to screen for prostate cancer, its value has come under question. Urine studies yield valuable diagnostic insights 9 GET IT CHECKED: Your GP will do a short rectal examination, as well as a PSA blood test for raised levels of prostate hormones. ...
In a large retrospective study of blood samples, the researchers showed that the method, called a "liquid biopsy," could accurately distinguishprostate cancerfrom normal controls without prior knowledge of the genetic "signature" of the tumors, and with over three times the sensitivity of current p...
Prostate cancer patients whose tumors contain a shortened protein called AR-V7, which can be detected in the blood, are less likely to respond to two widely used drugs for metastatic prostate cancer, according to results of a study led by researchers at
In blood test diagnostics, established use is made only of the levels of prostate-specific antigen (PSA) and free PSA. New methods for blood test diagnosis are "Prostate Health Index" and the four-kallikrein panel. 展开 被引量: 7